Inogen | INGN - Assets


Inogen reported $307.01M in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Abbott USD 110.43B 23.72B Mar/2026
Accuray USD 448.01M 8.81M Dec/2025
AngioDynamics USD 269.68M 4.04M Sep/2025
Artivion USD 883.16M 1.64M Mar/2026
AtriCure USD 643.99M 10.19M Mar/2026
Baxter International USD 19.85B 209M Mar/2026
Becton, Dickinson and Co. USD 50.83B 4.01B Mar/2026
Boston Scientific USD 44.35B 678M Mar/2026
Chart Industries USD 9.69B 114.8M Mar/2026
Cooper Companies USD 12.42B 29.4M Dec/2025
Dexcom USD 6.63B 293.4M Mar/2026
Edwards Lifesciences USD 13.32B 376M Mar/2026
Globus Medical USD 5.44B 136.79M Mar/2026
Inogen USD 307.01M 5.03M Sep/2025
Insulet USD 2.99B 203.2M Mar/2026
Masimo USD 1.64B 56.2M Mar/2026
Medtronic USD 91.48B 139M Dec/2025
Orthofix International USD 886.6M 35.95M Mar/2026
Philips EUR 27.27B 322M Mar/2026
ResMed USD 8.78B 280.91M Mar/2026
Steris USD 10.74B 145.8M Mar/2026
Stryker USD 46.29B 1.55B Mar/2026
Tandem Diabetes Care USD 1.15B 272.28M Mar/2026
Teleflex USD 6.78B 164.24M Mar/2026
X T L Biopharmaceuticals USD 714K 7.84M Jun/2025
Zimmer Biomet Holdings USD 22.72B 370.1M Mar/2026